Item Type | Name |
Academic Article
|
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
|
Academic Article
|
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
|
Academic Article
|
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
|
Academic Article
|
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
|
Academic Article
|
Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
|
Academic Article
|
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
|
Academic Article
|
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
|
Academic Article
|
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-?.
|
Academic Article
|
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
|
Academic Article
|
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
|
Academic Article
|
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
|
Academic Article
|
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
|
Academic Article
|
Posaconazole prophylaxis in hematologic cancer.
|
Academic Article
|
Random plasma concentrations of voriconazole decline over time.
|
Academic Article
|
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
|
Academic Article
|
Future directions in mucormycosis research.
|
Academic Article
|
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
|
Academic Article
|
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
|
Academic Article
|
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
|
Academic Article
|
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
|
Academic Article
|
Breakthrough zygomycosis and voriconazole.
|
Academic Article
|
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
|
Academic Article
|
Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection
|
Academic Article
|
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
|
Academic Article
|
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.
|
Academic Article
|
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
|
Academic Article
|
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
|
Academic Article
|
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
|
Academic Article
|
Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities.
|
Academic Article
|
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm.
|
Concept
|
Voriconazole
|
Academic Article
|
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
|
Academic Article
|
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
|
Academic Article
|
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
|